Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 1
1990 4
1991 5
1993 1
1994 4
1995 1
1996 3
1997 4
1998 3
1999 2
2000 4
2001 2
2003 1
2004 2
2005 1
2006 4
2007 1
2008 3
2010 1
2011 1
2013 2
2016 5
2017 6
2018 4
2019 4
2020 4
2021 2
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
The following terms were not found in PubMed: sanitaly, parafarmaco
Page 1
Astrocytes expressing Vitamin D-activating enzyme identify Parkinson's disease.
Mazzetti S, Barichella M, Giampietro F, Giana A, Calogero AM, Amadeo A, Palazzi N, Comincini A, Giaccone G, Bramerio M, Caronni S, Cereda V, Cereda E, Cappelletti G, Rolando C, Pezzoli G. Mazzetti S, et al. CNS Neurosci Ther. 2022 May;28(5):703-713. doi: 10.1111/cns.13801. Epub 2022 Feb 15. CNS Neurosci Ther. 2022. PMID: 35166042 Free PMC article.
INTRODUCTION: Astrocytes are involved in Parkinson's disease (PD) where they could contribute to alpha-Synuclein pathology but also to neuroprotection via alpha-Synuclein clearance. The molecular signature underlying their dual role is still elusive. Given that vitamin D h …
INTRODUCTION: Astrocytes are involved in Parkinson's disease (PD) where they could contribute to alpha-Synuclein pathology but also to neuro …
[New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention].
Gragnano F, Capolongo A, Terracciano F, Gargiulo G, Cesaro A, Moscarella E, De Sio V, Patti G, Porto I, Esposito G, Calabrò P. Gragnano F, et al. G Ital Cardiol (Rome). 2023 Feb;24(2):99-109. doi: 10.1714/3963.39417. G Ital Cardiol (Rome). 2023. PMID: 36735308 Review. Italian.
Dual antiplatelet therapy (DAPT) is a cornerstone in the management of patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI). ...
Dual antiplatelet therapy (DAPT) is a cornerstone in the management of patients with acute coronary syndrome (ACS) and/or undergoing …
A review of picotamide in the reduction of cardiovascular events in diabetic patients.
Celestini A, Violi F. Celestini A, et al. Vasc Health Risk Manag. 2007;3(1):93-8. Vasc Health Risk Manag. 2007. PMID: 17583179 Free PMC article. Review.
Picotamide is an antiplatelet drug with a dual inhibitory action. Thus, picotamide inhibits both thromboxane A2 (TxA2) receptors and TxA2 synthase and, at variance with aspirin, does not interfere with endothelial prostacyclin (PGI2) production. ...
Picotamide is an antiplatelet drug with a dual inhibitory action. Thus, picotamide inhibits both thromboxane A2 (TxA2) receptors and …
[Long-term antithrombotic strategies in post-myocardial infarction patients].
Perrone Filardi P, Caldarola P, Colivicchi F, Mugelli A, Varbella F, Paolillo S. Perrone Filardi P, et al. G Ital Cardiol (Rome). 2019 Nov;20(11 Suppl 1):e1-11. doi: 10.1714/3261.32286. G Ital Cardiol (Rome). 2019. PMID: 31772392 Italian.
Effective measures in terms of antithrombotic treatment and secondary prevention are currently available to reach these objectives. In particular, the use of dual antiplatelet therapy both in the 12 months after an acute event and in the long term is highly effective in re …
Effective measures in terms of antithrombotic treatment and secondary prevention are currently available to reach these objectives. In parti …
[Epidemiology and therapy of atrial fibrillation].
Capucci A, Aschieri D, Villani GQ. Capucci A, et al. Ann Ital Med Int. 1996 Oct;11 Suppl 2:5S-10S. Ann Ital Med Int. 1996. PMID: 9004821 Review. Italian.
Atrial fibrillation in patients with tachycardia-bradycardia syndrome is an important indication for permanent pacing. With the advent of dual chamber stimulation it has become apparent that atrioventricular sequential pacing may be superior to VVI pacing in patients with …
Atrial fibrillation in patients with tachycardia-bradycardia syndrome is an important indication for permanent pacing. With the advent of …
[Is it necessary to prescribe oral anticoagulant therapy for paroxysmal atrial fibrillation during acute coronary syndrome, and for how long?].
Visconti LO, Ferlini M, Rordorf R, Savastano S. Visconti LO, et al. G Ital Cardiol (Rome). 2019 Jun;20(6):361-366. doi: 10.1714/3165.31469. G Ital Cardiol (Rome). 2019. PMID: 31184322 Review. Italian.
In the last updates of the guidelines for the management of atrial fibrillation, non-vitamin K oral anticoagulants are recommended over warfarin and, in patients with atrial fibrillation who have undergone percutaneous coronary intervention with stenting for acute coronary syndro …
In the last updates of the guidelines for the management of atrial fibrillation, non-vitamin K oral anticoagulants are recommended over warf …
[Staged rotational atherectomy in a patient with acute ST-elevation myocardial infarction: a case report and review of the literature].
Franchina AG, Tomasello SD, Azzarelli SA, Scardaci F, Argentino V, Amico F. Franchina AG, et al. G Ital Cardiol (Rome). 2022 Feb;23(2):128-132. doi: 10.1714/3735.37215. G Ital Cardiol (Rome). 2022. PMID: 35343517 Review. Italian.
Vessel patency was obtained with balloon dilation, achieving clinical stability. The patient started dual antiplatelet therapy and was scheduled for a staged procedure using rotational atherectomy ("Rota-staged PCI"), performed 6 days later reaching optimal angiographic an …
Vessel patency was obtained with balloon dilation, achieving clinical stability. The patient started dual antiplatelet therapy and wa …
[Pharmacological strategy pre- and post-percutaneous coronary intervention in patients with acute coronary syndrome on oral anticoagulation therapy].
Franchina AG, Capodanno D. Franchina AG, et al. G Ital Cardiol (Rome). 2020 Feb;21(2 Suppl 1):26S-33S. doi: 10.1714/3311.32818. G Ital Cardiol (Rome). 2020. PMID: 32134405 Review. Italian.
In patients with atrial fibrillation (AF) who undergo an acute coronary syndrome (ACS), with or without percutaneous coronary intervention and coronary stent implantation, the association of dual antiplatelet therapy with an oral anticoagulant (also known as triple antithr …
In patients with atrial fibrillation (AF) who undergo an acute coronary syndrome (ACS), with or without percutaneous coronary intervention a …
80 results